Xanthoceraside attenuates amyloid β peptide25–35-induced learning and memory impairments in mice

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Psychopharmacology

• Publication date

  2011-07-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00213-011-2386-1PMID 21735075
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alzheimer's disease.

  2011cited by this paper
• CNS expression of anti‐inflammatory cytokine interleukin‐4 attenuates Alzheimer's disease‐like pathogenesis in APP+PS1 bigenic mice

  2010cited by this paper
• Protective effects of xanthoceraside on learning and memory impairment induced by intracerebroventricular injections of Aβ_(1-42) in mice

  2010cited by this paper
• Silibinin prevents amyloid β peptide‐induced memory impairment and oxidative stress in mice

  2009cited by this paper
• Silibinin Attenuates Amyloid (cid:1) 25–35 Peptide-Induced Memory Impairments: Implication of Inducible Nitric-Oxide Synthase and Tumor Necrosis Factor- (cid:2) in Mice

  2009cited by this paper
• Silibinin Attenuates Amyloid β25–35 Peptide-Induced Memory Impairments: Implication of Inducible Nitric-Oxide Synthase and Tumor Necrosis Factor-α in Mice

  2009cited by this paper
• Protective effects of xanthoceraside on learning and memory impairment induced by Aβ25–35 in mice

  2009influential reference
• Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice.

  2008cited by this paper
• Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein.

  2007cited by this paper
• Improvement of ethanol extract from husk of Xanthoceras sorbifolia on rats with learning and memory dysfunction

  2007cited by this paper
• A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by Abeta25-35.

  2007cited by this paper
• Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.

  2007cited by this paper
• Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment

  2007cited by this paper
• Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: autoantibodies to Abeta((25-35)) oligomers, S100b and neurotransmitters.

  2007cited by this paper
• A neural cell adhesion molecule–derived peptide reduces neuropathological signs and cognitive impairment induced by Aβ25-35

  2007cited by this paper
• The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1-42 in the rat hippocampus in vivo.

  2007cited by this paper
• IL‐4 attenuates the neuroinflammation induced by amyloid‐β in vivo and in vitro

  2007cited by this paper
• Connecting TNF-α Signaling Pathways to iNOS Expression in a Mouse Model of Alzheimer's Disease: Relevance for the Behavioral and Synaptic Deficits Induced by Amyloid β Protein

  2007cited by this paper
• Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1.

  2006cited by this paper
• The anti‐amnesic and neuroprotective effects of donepezil against amyloid β25‐35 peptide‐induced toxicity in mice involve an interaction with the σ1 receptor

  2006cited by this paper
• Alzheimer's disease

  2006cited by this paper
• Studies of the Effects of Central Administration of β-Amyloid Peptide (25–35): Pathomorphological Changes in the Hippocampus and Impairment of Spatial Memory

  2005cited by this paper
• Deciphering the molecular basis of memory failure in Alzheimer's disease.

  2004cited by this paper
• Amyloid-β(25–35)-induced memory impairments correlate with cell loss in rat hippocampus

  2004cited by this paper
• Tyrosine nitration of a synaptic protein synaptophysin contributes to amyloid β-peptide-induced cholinergic dysfunction

  2003influential reference
• Interleukin‐4 and interleukin‐10 modulate nuclear factor κB activity and nitric oxide synthase‐2 expression in Theiler's virus‐infected brain astrocytes

  2002cited by this paper
• The neurobiological basis of spontaneous alternation.

  2002cited by this paper
• Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.

  2002cited by this paper
• In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients.

  2002cited by this paper
• In vivo conversion of racemized β‐amyloid ([D‐Ser26]Aβ1–40) to truncated and toxic fragments ([D‐Ser26]Aβ25–35/40) and fragment presence in the brains of Alzheimer's patients

  2002cited by this paper
• Amyloid β‐peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors

  2001cited by this paper
• β-Amyloid Stimulation of Microglia and Monocytes Results in TNFα-Dependent Expression of Inducible Nitric Oxide Synthase and Neuronal Apoptosis

  2001cited by this paper
• β-Amyloid Induces Neuronal Apoptosis Via a Mechanism that Involves the c-Jun N-Terminal Kinase Pathway and the Induction of Fas Ligand

  2001cited by this paper
• beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.

  2001cited by this paper
• Subacute NO generation induced by Alzheimer's β‐amyloid in the living brain: reversal by inhibition of the inducible NO synthase

  2000cited by this paper
• Interleukin‐10, interleukin‐4, and transforming growth factor‐β differentially regulate lipopolysaccharide‐induced production of pro‐inflammatory cytokines and nitric oxide in co‐cultures of rat astroglial and microglial cells

  2000cited by this paper
• IFN-gamma and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation.

  2000cited by this paper
• Superoxide Reacts with Nitric Oxide to Nitrate Tyrosine at Physiological pH via Peroxynitrite*

  2000cited by this paper
• β-Amyloid Stimulation of Inducible Nitric-oxide Synthase in Astrocytes Is Interleukin-1β- and Tumor Necrosis Factor-α (TNFα)-dependent, and Involves a TNFα Receptor-associated Factor- and NFκB-inducing Kinase-dependent Signaling Mechanism*

  2000cited by this paper
• Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques.

  1999cited by this paper
• Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide.

  1998cited by this paper
• Induction of Nitric Oxide Synthase and Nitric Oxide‐Mediated Apoptosis in Neuronal PC12 Cells After Stimulation with Tumor Necrosis FActor‐α/Lipopolysaccharide

  1998cited by this paper
• Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques.

  1997cited by this paper
• Nitric Oxide‐Mediated Mitochondrial Damage in the Brain: Mechanisms and Implications for Neurodegenerative Diseases

  1997cited by this paper
• Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease

  1997influential reference
• Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.

  1996cited by this paper
• Activation of microglial cells by β-amyloid protein and interferon-γ

  1995cited by this paper
• Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity

  1995cited by this paper
• Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity.

  1995cited by this paper
• Activation of microglial cells by beta-amyloid protein and interferon-gamma.

  1995cited by this paper
• Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS.

  1994cited by this paper
• Inhibition of nitric oxide synthesis by interleukin‐4 may involve inhibiting the activation of protein kinase C epsilon

  1994cited by this paper
• Detection of Superoxide Production by Activated Microglia Using a Sensitive and Specific Chemiluminescence Assay and Microglia‐Mediated PC12h Cell Death

  1994cited by this paper
• Cytotoxicity of microglia

  1993cited by this paper
• Activated microglia mediate neuronal cell injury via a nitric oxide mechanism.

  1992cited by this paper
• Cloning and characterization of inducible nitric oxide synthase from mouse macrophages.

  1992cited by this paper

• Neuroprotective effects of pectolinarin against cognitive impairment in Aβ25-35-induced mouse model

  2025cites this paper
• Development of silibinin-loaded nanostructured lipid carriers for Alzheimer's disease induced by amyloid beta in Wistar rats.

  2024cites this paper
• Fosgonimeton attenuates amyloid-beta toxicity in preclinical models of Alzheimer's disease

  2024cites this paper
• Exploring the Anti-Alzheimer’s disease mechanism of Xanthoceraside based on GEO database and Network Pharmacology

  2023cites this paper
• GC/MS-Based Urine Metabolomics Study on the Ameliorative Effect of Xanthoceras sorbifolia Extract on Alzheimer's Disease in Mice

  2022cites this paper
• Loureirin C and Xanthoceraside Prevent Abnormal Behaviors Associated with Downregulation of Brain Derived Neurotrophic Factor and AKT/mTOR/CREB Signaling in the Prefrontal Cortex Induced by Chronic Corticosterone Exposure in Mice

  2022cites this paper
• The Aqueous Extract of Humulus japonicus Ameliorates Cognitive Dysfunction in Alzheimer's Disease Models via Modulating the Cholinergic System

  2022cites this paper
• Xanthoceraside exerts anti-Alzheimer's disease effect by remodeling gut microbiota and modulating microbial-derived metabolites level in rats.

  2022cites this paper
• Xanthoceraside administration produces significant antidepressant effects in mice through activation of the hippocampal BDNF signaling pathway.

  2021cites this paper
• Protective effects of Populus tomentiglandulosa against cognitive impairment by regulating oxidative stress in an amyloid beta25–35-induced Alzheimer's disease mouse model

  2021cites this paper
• Panax notoginseng saponins protect PC12 cells against Aβ induced injury via promoting parkin-mediated mitophagy.

  2021cites this paper
• Xanthoceras sorbifolium Bunge: A Review on Botany, Phytochemistry, Pharmacology, and Applications

  2021cites this paper
• Dehydroeffusol Rescues Amyloid β25–35-Induced Spatial Working Memory Deficit

  2020cites this paper
• Effects of the fermented Zizyphus jujuba in the amyloid β25-35-induced Alzheimer's disease mouse model

  2020cites this paper
• The protective effect of Xanthoceras sorbifolia Bunge husks on cognitive disorder based on metabolomics and gut microbiota analysis.

  2020cites this paper
• New barrigenol-type triterpenoids with anti-Alzheimer’s disease activity from Koelreuteria paniculata Laxm.

  2019cites this paper
• Natural barrigenol-like triterpenoids: A comprehensive review of their contributions to medicinal chemistry.

  2019cites this paper
• Xanthoceraside prevented synaptic loss and reversed learning-memory deficits in APP/PS1 transgenic mice

  2019cites this paper
• Variation and comprehensive evaluation of fruit and seed phenotypic traits of different mating combinations in Xanthoceras sorbifolium

  2019cites this paper
• Metabolomics analysis of Xanthoceras sorbifolia husks protection of rats against Alzheimer's disease using liquid chromatography mass spectrometry.

  2019cites this paper
• Xanthoceraside attenuates amyloid &bgr; peptide1‐42‐induced memory impairments by reducing neuroinflammatory responses in mice

  2018cites this paper
• Novel sarsasapogenin-triazolyl hybrids as potential anti-Alzheimer's agents: Design, synthesis and biological evaluation.

  2018cites this paper
• Determination and Pharmacokinetics of WGA in Rat Plasma by LC-MS After Oral Administration of Xanthoceras sorbifolia Bunge Extract.

  2018cites this paper
• Recent Trends in Drug Discovery against Alzheimer's Disease: Use of Natural Products and Nutraceuticals from Botanicals

  2018cites this paper
• Inhibitory effect of the leaves and stems of Actinidia arguta on Aβ (25-35)-induced neuronal cell death and memory impairment

  2018cites this paper
• A time-of-flight mass spectrometry based strategy to fast screen triterpenoids in Xanthoceras sorbifolia Bunge husks for bioactive substances against Alzheimer's disease

  2018cites this paper
• STUDY THE EFFECT OF SILIBININ ON EXPERIMENTALLY INDUCED MEMORY IMPAIRMENT IN MALE RATS.

  2018cites this paper
• Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions.

  2017cites this paper
• Effects of breviscapine on amyloid beta 1-42 induced Alzheimer's disease mice: A HPLC-QTOF-MS based plasma metabonomics study.

  2017cites this paper
• Xanthoceraside modulates neurogenesis to ameliorate cognitive impairment in APP/PS1 transgenic mice

  2017cites this paper
• Hydroxytyrosol restores proper insulin signaling in an astrocytic model of Alzheimer's disease

  2017cites this paper
• Xanthoceraside modulates NR2B-containing NMDA receptors at synapses and rescues learning-memory deficits in APP/PS1 transgenic mice

  2017cites this paper
• Phytochemicals as inhibitors of NF‐&kgr;B for treatment of Alzheimer's disease

  2017cites this paper
• The total triterpenoid saponins of Xanthoceras sorbifolia improve learning and memory impairments through against oxidative stress and synaptic damage.

  2017cites this paper
• Novel Therapeutic Strategies for Dementia.

  2016cites this paper
• Ursolic acid attenuates beta-amyloid-induced memory impairment in mice.

  2016influential citation
• A novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves Aβ25–35-impaired mouse cognitive function

  2016cites this paper
• Xanthoceraside hollow gold nanoparticles, green pharmaceutics preparation for poorly water-soluble natural anti-AD medicine.

  2016cites this paper
• Protective role of caffeic acid in an Aβ25-35-induced Alzheimer's disease model

  2015cites this paper
• Protective Effects of Silibinin and Its Possible Mechanism of Action in Mice Exposed to Chronic Unpredictable Mild Stress

  2015cites this paper
• Alzheimer’s Disease Pathology and Oxidative Stress: Possible Therapeutic

  2014cites this paper
• Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice.

  2014cites this paper
• Xanthoceraside Ameliorates Mitochondrial Dysfunction Contributing to the Improvement of Learning and Memory Impairment in Mice with Intracerebroventricular Injection of Aβ1-42

  2014cites this paper
• Xanthoceraside Induces Apoptosis in Melanoma Cells Through the Activation of Caspases and the Suppression of the IGF-1R/Raf/MEK/ERK Signaling Pathway

  2014cites this paper
• Pharmacogenomics in Drug Discovery and Development

  2014cites this paper
• Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development.

  2014cites this paper
• Alzheimer’s Disease Pathology and Oxidative Stress: Possible Therapeutic Options

  2014cites this paper
• Xanthoceraside attenuates learning and memory deficits via improving insulin signaling in STZ-induced AD rats.

  2013cites this paper
• Xanthoceraside attenuates tau hyperphosphorylation and cognitive deficits in intracerebroventricular-streptozotocin injected rats

  2013cites this paper
• Protective effect of xanthoceraside against β-amyloid-induced neurotoxicity in neuroblastoma SH-SY5Y cells

  2013cites this paper
• Voluntary exercise counteracts Aβ25-35-induced memory impairment in mice.

  2013cites this paper
• Blockade of Tau Hyperphosphorylation and Aβ1–42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and σ1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer’s Disease

  2013cites this paper
• Biodiesel production from Xanthoceras sorbifolia in China: Opportunities and challenges

  2013cites this paper
• Xanthoceraside inhibits pro-inflammatory cytokine expression in Aβ25-35/IFN-γ-stimulated microglia through the TLR2 receptor, MyD88, nuclear factor-κB, and mitogen-activated protein kinase signaling pathways.

  2013cites this paper
• Ameliorating effects of aged garlic extracts against Aβ-induced neurotoxicity and cognitive impairment

  2013cites this paper
• Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial

  2012cites this paper
• Efecto del beta Amiloide (25-35) sobre la respuesta inhibitoria mediada por canales Girk en la sinapsis fimbria-CA3 del hipocampo

  2012cites this paper